Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2021-04-16
Product name
LAPATINIB 250 MG TABLETS
Product Synonyms
GW572016F 250 MG TABLETS * LAPATINIB DITOSYLATE MONOHYDRATE, FORMULATED
1.2.1 Relevant identified uses
Bulk Formulated Product
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Hazardous to the aquatic environment, Category 4
Long term hazards
OSHA defined hazards Not classified.
Hazard pictograms
None.
Signal word
None.
Hazard statements
May cause long lasting harmful effects to aquatic life.
Prevention
Avoid release to the environment.
Response
Not available.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
41.7% of the mixture consists of component(s) of unknown acute oral toxicity. 97.1% of the mixture consists of component(s) of unknown acute dermal toxicity. 47.1% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 47.1% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
